These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 8773112
1. Xanthelasma palpebrum--a marker for hyperlipidemia in NIDDM patients? Premalatha G, Mohan V. J Assoc Physicians India; 1996 Jan; 44(1):73-4. PubMed ID: 8773112 [No Abstract] [Full Text] [Related]
2. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Ozdöl S, Sahin S, Tokgözoğlu L. Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856 [Abstract] [Full Text] [Related]
3. An Updated Work-Up for Patients With Xanthelasma Palpebrarum. Rothstein BE, Cohen JL. Dermatol Surg; 2021 Aug 01; 47(8):1170-1171. PubMed ID: 33988552 [No Abstract] [Full Text] [Related]
4. C-reactive protein in diabetes mellitus and hyperlipidemia. Khoja SM, Alabbassi FA, Abuelgassim AO, Al-Bar OA. Saudi Med J; 2004 Jan 01; 25(1):119-21. PubMed ID: 14758399 [No Abstract] [Full Text] [Related]
5. Case: asymptomatic lesions on eyelids. Levine N. Geriatrics; 2008 Aug 01; 63(8):31. PubMed ID: 18672954 [No Abstract] [Full Text] [Related]
6. [Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes]. Shishino K, Ochi M, Murase M, Osawa H, Makino H. Rinsho Byori; 2007 Aug 01; 55(8):705-11. PubMed ID: 17882792 [Abstract] [Full Text] [Related]
7. [Analysis of plasma lipids and clinical characteristics of patients with xanthelasma palpebrarum (author's transl)]. Zeman M, Zák A, Herdová J. Cas Lek Cesk; 1981 Jul 02; 120(26):806-8. PubMed ID: 7261000 [No Abstract] [Full Text] [Related]
8. [Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus]. Mel'chinskaia EN, Gromnatskiĭ NI, Kirichenko LL. Ter Arkh; 2000 Jul 02; 72(8):57-8. PubMed ID: 11019431 [Abstract] [Full Text] [Related]
9. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients. Seyoum B, Abdulkadir J, Berhanu P, Feleke Y, Mengistu Z, Worku Y, Ayana G. Ethiop Med J; 2003 Jan 02; 41(1):1-8. PubMed ID: 12764995 [Abstract] [Full Text] [Related]
10. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]. Wolffenbuttel BH, Huijberts MS. Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):761-5. PubMed ID: 11346911 [Abstract] [Full Text] [Related]
12. Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum. Kavoussi H, Ebrahimi A, Rezaei M, Ramezani M, Najafi B, Kavoussi R. An Bras Dermatol; 2016 Apr 21; 91(4):468-71. PubMed ID: 27579742 [Abstract] [Full Text] [Related]
13. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM). Uddin F, Miah AK. Bangladesh Med Res Counc Bull; 1995 Aug 21; 21(2):64-72. PubMed ID: 8815864 [Abstract] [Full Text] [Related]
14. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Ristić Medić D, Ristić V, Arsić A, Postić M, Ristić G, Blazencić Mladenović V, Tepsić J. Nutr Metab Cardiovasc Dis; 2006 Sep 21; 16(6):395-404. PubMed ID: 16935698 [Abstract] [Full Text] [Related]
15. Xanthelasma is not associated with increased risk of carotid atherosclerosis in normolipidaemia. Chan CC, Lin SJ, Hwang JJ, Sun CC, Jeng JS, Hwang BS, Chiu HC, Chen MF, Liau CS, Hsu HJ, Su TC. Int J Clin Pract; 2008 Feb 21; 62(2):221-7. PubMed ID: 18036167 [Abstract] [Full Text] [Related]
16. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Matsumoto K, Fujita N, Nakamura K, Senoo T, Tominaga T, Ueki Y. Diabetes Res Clin Pract; 2008 Oct 21; 82(1):93-7. PubMed ID: 18684539 [Abstract] [Full Text] [Related]